Independent company use-case study · biosolutions

NovonesisFive process decisions

Choose one use case. Add authorised plant data. Test capacity, cost and constraints.
Acatian flowsheet workspace for a Novonesis process decision
Assumptions, equipment, capacity, cost and evidence on one model basis.

Decision brief

One question. One model.

Decision

Advance one biosolution or process option only after functional requirements, product quality, scale risk, finite capacity, economics, environmental inventory and missing evidence remain explicit on the same scenario basis.

System boundary

Authorised substrate, enzyme, culture or formulation inputs through reaction or fermentation, separation, concentration, drying or finishing, packaging, cleaning, utilities, quality holds, waste and accepted product for one declared application.

Five practical use cases

Five places to start.

Evaluation scopes for Novonesis—not claims of current software use.
01

Compare biosolutions on a process basis

Carry an authorised enzyme, culture, dosage or formulation option into kinetics, material yield, process time, quality limits, equipment duty and accepted output before selecting the next experiment.

02

Build a fermentation scale-up evidence path

Translate laboratory or pilot runs into mixing, gas-transfer, heat-removal, feed, separation and drying envelopes, then identify the study needed before the next production gate.

03

Schedule multiproduct biosolutions campaigns

Sequence eligible fermenters, seed trains, separators, concentrators, dryers, packaging, cleaning, laboratories and release holds without representing a real Novonesis plan or constraint.

04

Compare biosolution and reference-route TEA/LCA

Evaluate functionally equivalent routes across materials, yield, energy, water, waste, cost and lifecycle inventory while preserving the functional unit, system boundary and evidence quality.

05

Govern product and process change evidence

Link requirements, sources, formulation and process versions, experiments, specifications, deviations and acceptance criteria while keeping model checks separate from formal quality and regulatory approval.

Action pack

Inputs in. Decisions out.

Minimum inputs
  • Application, recipe, functional target and quality basis
  • Enzyme or culture kinetics, yield and repeat-run evidence
  • Equipment eligibility, scale rules, cleaning and release timing
  • Material, utility, waste, cost and lifecycle factors
Required outputs
  • Biosolution-to-process option comparison
  • Scale-up and equipment-fit evidence map
  • Finite campaign schedule and accepted-output range
  • Cost, lifecycle inventory and change-evidence register
First three steps
  • Select one authorised application and decision.
  • Declare the functional, product and process boundary.
  • Import recipe, experiment and equipment evidence.

Evidence and limits

Public evidence only.

  1. Novonesis — Dairy biosolutionsOfficial context for recipe trials, yield and quality optimisation, scale-up, digital services and data analysis in dairy applications.
  2. Novonesis — Innovation CampusOfficial context for feasibility, implementation and optimisation of enzymatic processes plus high-throughput proof of concept.
  3. Novonesis — North AmericaOfficial context for a multipurpose enzyme-production site and biosolutions manufacturing footprint.
  4. Novonesis — 2025 performance highlightsOfficial context for current business divisions, financial performance and sustainability priorities.

Guardrail: No Novonesis recipe, product claim, customer, site, system, schedule, cost, environmental result, deployment or performance value is represented. Safety, sensory, efficacy, quality, regulatory, investment and release decisions remain within approved Novonesis and customer processes.